Laffer Tengler Investments Bristol Myers Squibb CO Transaction History

Laffer Tengler Investments

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $2,817 - $3,709	-70 Reduced 7.0%	930 $38.6 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $3,358 - $3,808	70 Added 7.53%	1,000 $54.2 Million
Q3 2021 Nov 16, 2021	BUY	$59.17 - $69.31 $55,028 - $64,458	930 New	930 $55 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $57,576 - $62,700	-930 Closed	0 $0
Q4 2020 Jun 11, 2021	BUY	$57.74 - $65.43 $53,698 - $60,849	930 New	930 $57.6 Million
Q4 2020 Feb 19, 2021	SELL	$57.74 - $65.43 $53,698 - $60,849	-930 Closed	0 $0
Q2 2020 Jun 11, 2021	BUY	$54.82 - $64.09 $50,982 - $59,603	930 New	930 $54.7 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $3.04 Million - $3.5 Million	-50,721 Closed	0 $0
Q3 2017 Nov 16, 2017	BUY	$55.23 - $63.74 $2.8 Million - $3.23 Million	50,721	50,721 $3.23 Billion

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

Stay updated on Laffer Tengler Investments with notifications on news.